ixekizumab
eli lilly
['ibd', ' psa', 'ixekizumab']
ab1042 #acr22 ixekizumab long-term safety
a deodhar: pooled 25 studies for pso, psa, as 5.4 pooled ae per 100-patient/year
0.5 ibd per 100-py
1.3 oral candidiasis per 100-py re-assuring safety numbers. deodhar: "these are numbers to use in clinical practice" 
Rheumatologist at Institute for Rheumatic and Autoimmune Disease at Overlook Hospital, proud Hopkins alum, health care advocate, Eagles fan entering Giants land